207- Aloush V, Ablin JN, Reitblat T, Caspi D, Elkayam O. Fibromyalgia in women with ankylosing
spondylitis. Rheumatol Int. 2007;27(9):865–8. - Staud R. Are patients with systemic lupus erythematosus at increased risk for fi bromyalgia?
Curr Rheumat Rep. [Review]. 2006;8(6):430–35. - Bennett R. The concurrence of lupus and fi bromyalgia: implications for diagnosis and man-
agement. Lupus. [Review]. 1997;6(6):494–9. - Pompa A, Clemenzi A, Troisi E, Pace L, Casillo P, Catani S, et al. Chronic pain in multiple
sclerosis patients: utility of sensory quantitative testing in patients with fi bromyalgia comor-
bidity. Eur Neurol. 2015;73(5–6):257–63. - Clemenzi A, Pompa A, Casillo P, Pace L, Troisi E, Catani S, et al. Chronic pain in multiple
sclerosis: is there also fi bromyalgia? An observational study. Med Sci Monitor. [Observational
Study Research Support, Non-U.S. Gov’t]. 2014;20:758–66. - Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people
with fi bromyalgia. BMC Musculoskelet Disord. 2007;8:27. - Wright M. Widespread body pain and mortality. Diagnosing fi bromyalgia stops doctors from
thinking. Br Med J. [Comment Letter]. 2002;324(7332):300. - Chamizo-Carmona E. [Is there an association between fi bromyalgia and an increase in comor-
bidity: neoplastic and cardiovascular diseases, infections and mortality?]. Article in Spanish.
Reumatol Clin. 2005;1(4):200–10. - Wolfe F, Hassett AL, Walitt B, Michaud K. Mortality in fi bromyalgia: a study of 8,186 patients
over thirty-fi ve years. Arthritis Care Res. [Comparative Study]. 2011;63(1):94–101. - Dreyer L, Kendall S, Danneskiold-Samsoe B, Bartels EM, Bliddal H. Mortality in a cohort of
Danish patients with fi bromyalgia: increased frequency of suicide. Arthritis Rheum. [Research
Support, Non-U.S. Gov’t]. 2010;62(10):3101–8. - Bennett RM, Friend R, Marcus D, Bernstein C, Han BK, Yachoui R, et al. Criteria for the
diagnosis of fi bromyalgia: validation of the modifi ed 2010 preliminary American College of
Rheumatology criteria and the development of alternative criteria. Arthritis Care Res.
2014;66(9):1364–73. - Choy EH, Arnold LM, Clauw DJ, Crofford LJ, Glass JM, Simon LS, et al. Content and crite-
rion validity of the preliminary core dataset for clinical trials in fi bromyalgia syndrome.
J Rheumatol. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t].
2009;36(10):2330–4. - Castrejon I, Gossec L, Carmona L. The EULAR outcome measures library: an evolutional
database of validated patient-reported instruments. Ann Rheum Dis. [Letter]. 2015;
74(2):475–6. - Bennett R. The fi bromyalgia impact questionnaire (FIQ): a review of its development, current
version, operating characteristics and uses. Clin Exp Rheumatol. 2005;23(5 Suppl
39):S154–62. - Burckhardt CS, Clark SR, Bennett RM. The fi bromyalgia impact questionnaire: development
and validation. J Rheumatol. 1991;18(5):728–33. - Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The revised fi bromyalgia
impact questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther.
[Research Support, Non-U.S. Gov’t Validation Studies]. 2009;11(4):R120. - Ediz L, Hiz O, Toprak M, Tekeoglu I, Ercan S. The validity and reliability of the Turkish ver-
sion of the revised fi bromyalgia impact questionnaire. Clin Rheumatol. [Validation Studies].
2011;30(3):339–46. - Zachrisson O, Regland B, Jahreskog M, Kron M, Gottfries CG. A rating scale for fi bromyalgia
and chronic fatigue syndrome (the fi brofatigue scale). J Psychosom Res. [Clinical Trial
Controlled Clinical Trial]. 2002;52(6):501–9. - Brand K, Littlejohn G, Kristjanson L, Wisniewski S, Hassard T. The fi bromyalgia bladder
index. Clin Rheumatol. 2007;26(12):2097–103. - Vallejo MA, Rivera J, Esteve-Vives J, Rejas J. A confi rmatory study of the combined index of
severity of fi bromyalgia (ICAF*): factorial structure, reliability and sensitivity to change.
Health Qual Life outcomes. [Research Support, Non-U.S. Gov’t Validation Studies]. 2011;9:39.
7 PROMs for Fibromyalgia